Winner Profile
Igor Krylov
CEO, Pharmstandard
Industry: Pharmaceuticals
Company size: Large
Published: 2016-10-17
Is Pharmstandard a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Igor Krylov (Pharmstandard) earned the following Obermatt pins for the management performance.
Obermatt accolades Igor Krylov
| Year | Pin | Category |
|---|---|---|
| 2016 |  |
Growth Performance |
| 2014 |  |
Operating Performance |
Igor Krylov was included in the competition among Mid-sized Companies (Russia) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Igor Krylov
In summary, Igor Krylov obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 38 in Combined Performance indicates that Igor Krylov was better than 38% of all other CEOs that were analyzed as part of the Mid-sized Companies – Russia for three participations in Obermatt CEO competitions. Igor Krylov’s average ranking can be found in the Multi-Year Rankings for Mid-sized Companies - Russia.